Recordati S.p.A.: Recordati's revenue changed from $2.44B in Jun 2024 to $2.52B in Sep 2024
Recordati’s Trailing Twelve Months revenue changed from $2.44B in Jun 2024 to $2.52B in Sep 2024 increasing 3.3% in this time period.
Read full article »
Recordati engages in the research, development, manufacture, marketing and sale of pharmaceutical drugs for the treatment of rare diseases.
Read more